IRIS Accounts Production v23.2.0.158 09388779 director 1.4.22 31.3.23 31.3.23 0 0 false true false false true false Ordinary 100.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093887792022-03-31093887792023-03-31093887792022-04-012023-03-31093887792021-03-31093887792021-04-012022-03-31093887792022-03-3109388779ns10:Originalns15:EnglandWales2022-04-012023-03-3109388779ns14:PoundSterlingns10:Original2022-04-012023-03-3109388779ns10:Originalns10:Director12022-04-012023-03-3109388779ns10:Original2022-04-012023-03-3109388779ns10:Original2023-03-3109388779ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3109388779ns10:Originalns10:SmallEntities2022-04-012023-03-3109388779ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3109388779ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3109388779ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3109388779ns10:Originalns10:FullAccounts2022-04-012023-03-3109388779ns10:Original2021-04-012022-03-3109388779ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3109388779ns10:CompanySecretary1ns10:Original2022-04-012023-03-3109388779ns10:Originalns10:RegisteredOffice2022-04-012023-03-3109388779ns10:Original2022-03-3109388779ns10:Originalns5:CurrentFinancialInstruments2023-03-3109388779ns10:Originalns5:CurrentFinancialInstruments2022-03-3109388779ns5:ShareCapitalns10:Original2023-03-3109388779ns5:ShareCapitalns10:Original2022-03-3109388779ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3109388779ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3109388779ns10:Originalns5:FurnitureFittings2022-03-3109388779ns10:Originalns5:ComputerEquipment2022-03-3109388779ns10:Original2022-03-3109388779ns10:Originalns5:FurnitureFittings2022-04-012023-03-3109388779ns10:Originalns5:ComputerEquipment2022-04-012023-03-3109388779ns10:Originalns5:FurnitureFittings2023-03-3109388779ns10:Originalns5:ComputerEquipment2023-03-3109388779ns10:Originalns5:FurnitureFittings2022-03-3109388779ns10:Originalns5:ComputerEquipment2022-03-3109388779ns10:Originalns10:OrdinaryShareClass12023-03-3109388779ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3109388779ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-04-012023-03-31
REGISTERED NUMBER: 09388779 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

CORONARY SOLUTIONS LTD

CORONARY SOLUTIONS LTD (Registered number: 09388779)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CORONARY SOLUTIONS LTD

Company Information
for the Year Ended 31 March 2023







DIRECTOR: DR K Mahmood





SECRETARY:





REGISTERED OFFICE: Apt 11 Arbury House
28 School Lane
Solihull
West Midlands
B91 2QN





REGISTERED NUMBER: 09388779 (England and Wales)





ACCOUNTANTS: Paul Lewis & Associates
1 Templeton Close
Dorridge
Solihull
West Midlands
B93 8LS

CORONARY SOLUTIONS LTD (Registered number: 09388779)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 312 481
Investments 5 (1 ) (1 )
311 480

CURRENT ASSETS
Cash at bank 73,689 53,648

CREDITORS
Amounts falling due within one year 6 12,476 12,458
NET CURRENT ASSETS 61,213 41,190
TOTAL ASSETS LESS CURRENT
LIABILITIES

61,524

41,670

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 61,424 41,570
SHAREHOLDERS' FUNDS 61,524 41,670

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 November 2023 and were signed by:





DR K Mahmood - Director


CORONARY SOLUTIONS LTD (Registered number: 09388779)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

CORONARY SOLUTIONS LTD is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

CORONARY SOLUTIONS LTD (Registered number: 09388779)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2022
and 31 March 2023 582 4,688 5,270
DEPRECIATION
At 1 April 2022 419 4,370 4,789
Charge for year 105 64 169
At 31 March 2023 524 4,434 4,958
NET BOOK VALUE
At 31 March 2023 58 254 312
At 31 March 2022 163 318 481

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2022
PROVISIONS
At 1 April 2022
and 31 March 2023 1
NET BOOK VALUE
At 31 March 2023 (1 )
At 31 March 2022 (1 )

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Tax 5,479 2,245
Proposed dividends 2,666 6,000
Other creditors 900 1,406
Accountancy Fees Accrued 1,150 1,000
Spire Room Rent 1,000 1,800
Directors' current accounts 1,281 7
12,476 12,458

7. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
100 Share capital 1 100 100 100

CORONARY SOLUTIONS LTD (Registered number: 09388779)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. RESERVES
Retained
earnings
£   

At 1 April 2022 41,570
Profit for the year 23,187
Dividends (3,333 )
At 31 March 2023 61,424